Latest Articles

Publication Date
Intraoperative transvaginal ultrasound to refine surgical strategy in rectosigmoid endometriosis.

To explore the role of intraoperative transvaginal ultrasound in surgical planning for bowel deep endometriosis involving the rectum, rectosigmoid junction, and inferior sigmoid colon [1].

Published: Jan. 9, 2026, midnight
Surgical Management of Disseminated Peritoneal Leiomyomatosis.

The objective of this video is to describe a case of disseminated peritoneal leiomyomatosis (DPL) mimicking deeply infiltrating endometriosis and discuss the preoperative workup, intraoperative approach, and postoperative considerations. We …

Published: Jan. 9, 2026, midnight
Regarding "Is endometriosis staging related to the type and intensity of patients' complaints? A systematic review and meta-analysis".

Firstly, this meta-analysis[1] included a total of eight studies, seven of which used the rASRM classification, while only one applied the ENZIAN classification; the latter was not included in the …

Published: Jan. 9, 2026, midnight
The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review.

This systematic review aimed to summarize the effects of astaxanthin (ASX) supplementation on oxidative stress, inflammation, and metabolic regulation in human studies. A systematic search was conducted in Scopus, Web …

Published: Jan. 9, 2026, midnight
2026 world cup usa knockout stage player of the tournament trends - July 2025 Sector Moves & Low Risk High Win Rate Picks - ulpravda.ru

2026 world cup usa knockout stage player of the tournament trends - July 2025 Sector Moves & Low Risk High Win Rate Picks ulpravda.ru

Published: Jan. 8, 2026, 11:10 p.m.
Focused Clinical Strategy and Accelerated Approval Path for ACR-368 in High-Need Serous Endometrial Cancer Underpin ACRV Buy Rating - TipRanks

Focused Clinical Strategy and Accelerated Approval Path for ACR-368 in High-Need Serous Endometrial Cancer Underpin ACRV Buy Rating TipRanks

Published: Jan. 8, 2026, 7:11 p.m.
Acrivon's ACR-368 Shows 52% Response Rate In Endometrial Cancer, Expands Trial To Europe - Nasdaq

Acrivon's ACR-368 Shows 52% Response Rate In Endometrial Cancer, Expands Trial To Europe Nasdaq

Published: Jan. 8, 2026, 1:42 p.m.
Acrivon reports 52% response rate in serous endometrial cancer trial By Investing.com - Investing.com Australia

Acrivon reports 52% response rate in serous endometrial cancer trial By Investing.com Investing.com Australia

Published: Jan. 8, 2026, 1:10 p.m.
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 - The Manila Times

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 …

Published: Jan. 8, 2026, 12:53 p.m.
Eutopic Endometrium Immune Changes Involved in Development and Progression of Endometriosis: A Review.

Numerous abnormalities of the endometriosis eutopic endometrium contribute to the initiation and development of ectopic lesions. It is also believed that among the complex causes of the disease, systemic immunological …

Published: Jan. 8, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!